You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Glenmark Pharms Ltd Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has eighty-four approved drugs.

There are eight tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for Glenmark Pharms Ltd
US Patents:0
Tradenames:72
Ingredients:68
NDAs:84

Drugs and US Patents for Glenmark Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd ICATIBANT ACETATE icatibant acetate INJECTABLE;SUBCUTANEOUS 213222-001 May 21, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd EZETIMIBE ezetimibe TABLET;ORAL 078560-001 Jun 26, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd TELMISARTAN telmisartan TABLET;ORAL 090032-001 Jul 7, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd LIDOCAINE lidocaine OINTMENT;TOPICAL 206498-001 Sep 9, 2016 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd RUFINAMIDE rufinamide TABLET;ORAL 205075-002 May 16, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd LACOSAMIDE lacosamide TABLET;ORAL 205006-002 Mar 17, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 203281-003 May 25, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.